Cargando…

Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients

BACKGROUND: SARS-CoV-2, the cause of coronavirus disease 2019 (COVID-19), is associated with respiratory-related morbidity and mortality. Assays to detect virus-specific antibodies are important to understand the prevalence of infection and the course of the immune response. METHODOLOGY: Quantitativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burbelo, Peter D., Riedo, Francis X., Morishima, Chihiro, Rawlings, Stephen, Smith, Davey, Das, Sanchita, Strich, Jeffrey R., Chertow, Daniel S., Davey, Richard T., Cohen, Jeffrey I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239070/ https://www.ncbi.nlm.nih.gov/pubmed/32511445 http://dx.doi.org/10.1101/2020.04.20.20071423

Ejemplares similares

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022)

1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation
por: Warner, Seth, et al.
Publicado: (2022)

451. Is Antibody to Nucleocapsid More Prevalent in Individuals with Severe COVID-19?
por: Patel, Hemang, et al.
Publicado: (2021)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
por: Midorikawa, Rie, et al.
Publicado: (2022)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

249. SARS-CoV-2 Spike Immune Complexes Induce NETosis in COVID-19
por: Allen, Kiana C, et al.
Publicado: (2023)

Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms
por: Varnai, Reka, et al.
Publicado: (2022)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

Antibodies to Nucleocapsid Are Not Diagnostic for Long COVID
por: Brandt, C. T., et al.
Publicado: (2023)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens
por: Favara, D. M., et al.
Publicado: (2020)

IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
por: Tutukina, Maria, et al.
Publicado: (2021)

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma
por: Thomopoulos, Thomas P., et al.
Publicado: (2021)

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan
por: Furukawa, Hiroshi, et al.
Publicado: (2022)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

Comparison of nucleocapsid and spike antibody ELISAs for determining SARS‐CoV‐2 seropositivity in Kenyan women and infants
por: Fish, Carolyn S., et al.
Publicado: (2022)

Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production
por: Cortés-Sarabia, Karen, et al.
Publicado: (2022)

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays
por: Shah, Jyotsna, et al.
Publicado: (2021)

Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
por: Schuler, Charles F., et al.
Publicado: (2021)

Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles
por: Soares, Sinei Ramos, et al.
Publicado: (2023)

Tracking hantavirus nucleocapsid protein using intracellular antibodies
por: Li, Jiandong, et al.
Publicado: (2010)

Antibody tests: They are more important than we thought()
por: Guimarães, Luís
Publicado: (2021)

Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19
por: Flinck, Heini, et al.
Publicado: (2021)

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2020)

Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
por: Liu, Wanbing, et al.
Publicado: (2020)

A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays
por: Poore, Brad, et al.
Publicado: (2021)

A novel colorimetric biosensor for detecting SARS-CoV-2 by utilizing the interaction between nucleocapsid antibody and spike proteins
por: Bhattacharjee, Abhishek, et al.
Publicado: (2022)

Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls
por: Søfteland, John M., et al.
Publicado: (2022)

Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein
por: Cate, David M., et al.
Publicado: (2021)

Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic
por: Strich, Jeffrey R, et al.
Publicado: (2020)

The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA
por: Paul, Gregor, et al.
Publicado: (2022)

High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19
por: Ko, Sung Hee, et al.
Publicado: (2021)

High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19
por: Ko, Sung Hee, et al.
Publicado: (2021)

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
por: Van Elslande, Jan, et al.
Publicado: (2022)

SARS COV-2 anti-nucleocapsid and anti-spike antibodies in an emergency department healthcare worker cohort: September 2020 – April 2021
por: Wang, Ralph C., et al.
Publicado: (2022)

Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
por: Yang, Huijie, et al.
Publicado: (2023)

Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies
por: Sottini, Alessandra, et al.
Publicado: (2020)

Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!
por: Mveang Nzoghe, Amandine, et al.
Publicado: (2021)

Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus
por: Satoh, Ryoichi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b16n3kp9nju7smglokiugchtcn